Literature DB >> 639833

Bioavailability of p-chlorophenoxyisobutyric acid (clofibrinic acid) after repeated doses of its calcium salt to humans.

T Taylor, L F Chasseaud, A Darragh, D A O'Kelly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 639833     DOI: 10.1007/BF00606682

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  17 in total

1.  Pharmacokinetics of clofibrate and chlorophenoxy isobutyric aicd. I. Cross-over studies on human volunteers.

Authors:  P T Männistö; J Tuomisto; A Jounela; O Penttilä
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-04

2.  The use of confidence intervals in biopharmaceutics.

Authors:  E Shirley
Journal:  J Pharm Pharmacol       Date:  1976-04       Impact factor: 3.765

3.  Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxy-isobutyrate.

Authors:  J M THROP
Journal:  Lancet       Date:  1962-06-23       Impact factor: 79.321

4.  [Pharmacokinetic study in man of hypolipemic agents derived from clofibric acid after single and repeated administration].

Authors:  A Cailleux; P Allain; A Tadei
Journal:  Therapie       Date:  1976 Sep-Oct       Impact factor: 2.070

5.  Lack of effect of cholestyramine on the pharmacokinetics of clofibrate in man.

Authors:  A Sedaghat; E H Ahrens
Journal:  Eur J Clin Invest       Date:  1975-04       Impact factor: 4.686

6.  Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs.

Authors:  A M Barrett; J M Thorp
Journal:  Br J Pharmacol Chemother       Date:  1968-02

7.  Bioavailability--a problem in equivalence.

Authors:  C M Metzler
Journal:  Biometrics       Date:  1974-06       Impact factor: 2.571

8.  Plasma concentrations and bioavailability of clofibric acid from its calcium salt in humans.

Authors:  T Taylor; L F Chasseaud
Journal:  J Pharm Sci       Date:  1977-11       Impact factor: 3.534

9.  A gas-liquid chromatographic determination of p-chlorophenoxyisobutyric acid and its comparison to an ultra violet method.

Authors:  H Bruderlein; W T Robinson; M Kraml; D Dvornik
Journal:  Clin Biochem       Date:  1975-08       Impact factor: 3.281

10.  Clofibrate pharmacokinetics: effect of elevation of plasma-free fatty acids.

Authors:  W G Crouthamel; R J Cenedella
Journal:  Pharmacology       Date:  1975       Impact factor: 2.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.